- In May 2024, Fresenius Medical Care, a global leader in dialysis products and services, announced the expansion of its home dialysis portfolio with the introduction of a next-generation hemodialysis system designed for easier self-administration and enhanced patient comfort. This launch reflects the company’s commitment to patient-centric innovation and the growing shift toward home-based care. The system’s intuitive design and integrated connectivity features enable real-time monitoring and remote assistance, aiming to improve treatment adherence and outcomes for chronic kidney disease patients
- In April 2024, Baxter International Inc. introduced a new range of portable peritoneal dialysis (PD) cyclers equipped with advanced fluid management and telehealth integration capabilities. Designed to support the increasing demand for remote and home dialysis options, the new system enhances flexibility and empowers patients to manage their therapy independently. This innovation aligns with the broader healthcare trend of decentralizing chronic care and improving patient quality of life
- In March 2024, Nipro Corporation announced the establishment of a new dialysis consumables manufacturing plant in Thailand to strengthen its production capacity across the Asia-Pacific region. This strategic expansion aims to meet the rising demand for high-quality hemodialysis supplies and reduce supply chain risks. Nipro’s investment highlights the growing importance of local production in ensuring timely availability of dialysis products in rapidly expanding regional markets
- In February 2024, Outset Medical, Inc. received expanded FDA clearance for its Tablo Hemodialysis System to be used across all care settings, including the home. This marks a significant regulatory milestone, enabling broader access to flexible, user-friendly dialysis equipment. The decision underscores the U.S. healthcare system’s ongoing shift toward home-based treatment solutions and the increasing reliance on smart, connected medical devices
- In January 2024, B. Braun Melsungen AG entered into a strategic partnership with an African healthcare provider network to supply affordable, high-quality dialysis consumables across select regions. This initiative aims to expand dialysis access in underserved markets and promote equitable renal care. Through localized distribution and training programs, the collaboration supports B. Braun’s mission to improve global healthcare access and address disparities in kidney disease management
